Cargando…

P12-02. Cell-surface display and panning of HIV-1 derived envelope proteins

Detalles Bibliográficos
Autores principales:	Bruun, T, Kliche, A, Wagner, R
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767657/ http://dx.doi.org/10.1186/1742-4690-6-S3-P168

Ejemplares similares

A Mammalian Cell Based FACS-Panning Platform for the Selection of HIV-1 Envelopes for Vaccine Development
por: Bruun, Tim-Henrik, et al.
Publicado: (2014)

Mammalian cell surface display for monoclonal antibody-based FACS selection of viral envelope proteins
por: Bruun, Tim-Henrik, et al.
Publicado: (2017)

P05-01. Generation of a HI-viral packaging cell line as scaffolding for a lentiviral display system
por: Schilling, K, et al.
Publicado: (2009)

P05-13. Fragments of HIV-1 gp41 derivatives presented on virus-like particles with preserved binding affinity for broadly neutralizing antibodies
por: Benen, T, et al.
Publicado: (2009)

P12-05. Using combinatorial phage-display libraries as a source of mimetic peptides of three HIV-1 envelope epitopes
por: Palacios-Rodriguez, Y, et al.
Publicado: (2009)

P02-02. Analysis of antigen specific degranulation potentials using IL-12 or IL-28B during HIV DNA Vaccination
por: Morrow, M, et al.
Publicado: (2009)

P12-01. Construction and characterization of recombinant envelope glycoproteins derived from HIV-1 pre-seroconversion strains as potential vaccine immunogens
por: Reddy, S Mohana Rama, et al.
Publicado: (2009)

P12-10. Immunogen utilizing the stable interaction of cytoplasmic tails of HIV-1 envelope and cores
por: Takahashi, H, et al.
Publicado: (2009)

The impact of HLA-Cw*12:02 on control of HIV-1 infection
por: Koyanagi, M, et al.
Publicado: (2012)

Yeast surface display of HIV Env protein variants for the discovery of novel vaccine immunogens
por: Grimm, S, et al.
Publicado: (2012)

Mass spectrometry analysis of HIV-1 envelop proteins
por: Galkin, A, et al.
Publicado: (2009)

P11-21. Induction of persistent mucosal humoral and cellular responses following immunization of mice with HIV-1 envelope protein in inulin-derived adjuvants
por: Cristillo, AD, et al.
Publicado: (2009)

PA02.12. Toxicity studies on shankha vati
por: Kodlady, Naveena, et al.
Publicado: (2013)

P02-12. Bupivacaine, a local anaesthetic, enhances immunogenicity of a multiepitopic DNA vaccine containing HIV promiscuous CD4 T cell epitopes
por: Rosa, DS, et al.
Publicado: (2009)

Mapping antigenic variation in HIV-1 envelope
por: Frost, Simon
Publicado: (2013)

P02.37. Mindfulness for caregivers
por: Bloom, P, et al.
Publicado: (2012)

P02.184. Abstract withdrawn
Publicado: (2012)

P02-09. Dissecting the interference of endotoxins with HIV infection of primary CD4 T cell
por: Krarup, A, et al.
Publicado: (2009)

P02.19. Resilience training for depressed healthcare workers: results from 2 and 12 month followup
por: Dusek, J, et al.
Publicado: (2012)

P12-11. Resistance to the CD4 mimetic mini protein M48-U1 induces changes in a highly conserved region on the HIV-1 gp120 envelope protein
por: Grupping, K, et al.
Publicado: (2009)

P09-12. Autologous neutralizing antibodies in early subtype C HIV-1 infection target variable regions of envelope and drive multiple pathways of viral escape
por: Rong, R, et al.
Publicado: (2009)

Anti-HIV and immune modulating activities of IND02
por: Biedma, ME, et al.
Publicado: (2012)

P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine
por: Liu, J, et al.
Publicado: (2009)

P05-10. Sequential immunization with a subtype B HIV-1 envelope quasispecies elicits broader neutralization than vaccination with a single envelope clone
por: Malherbe, DC, et al.
Publicado: (2009)

P17-09. Immunization with a single HIV-1 envelope sequence can generate CD8+ T lymphocytes capable of recognizing multiple variant forms of envelope
por: Hulot, SL, et al.
Publicado: (2009)

Epitopes recognised by neutralising and non-neutralising anti-envelope antibodies define surface exposed regions of HTLV-1 envelope
por: Brighty, David W, et al.
Publicado: (2014)

Display of the HIV envelope protein at the yeast cell surface for immunogen development
por: Mathew, Elizabeth, et al.
Publicado: (2018)

P02-08. Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant
por: Sun, J, et al.
Publicado: (2009)

P17-02. PolyCTLDesigner: the software for constructing highly efficient polyepitope immunogens. Application to HIV-1
por: Antonets, D, et al.
Publicado: (2009)

P04-43. Neutralizing antibody responses against conformational envelope epitopes in early HIV-1 infection
por: Bar, KJ, et al.
Publicado: (2009)

P05-03. The use of immune complexes to enhance antibody responses against neutralizing epitopes on HIV envelope
por: Hioe, CE, et al.
Publicado: (2009)

P05-05. Enhanced immunogenicity of HIV-1 envelope glycoprotein trimers fused to CD40 ligand
por: Melchers, M, et al.
Publicado: (2009)

P20-15. Evaluation of HIV-1 subtype B acute envelope-expressing infectious molecular clones
por: Siddiqui, AA, et al.
Publicado: (2009)

P04-49 LB. Adaptation of HIV-1 envelope glycoprotein to humoral immunity at a population level
por: Bunnik, EM, et al.
Publicado: (2009)

P02.168. Safety issues and orthorexia in paediatrics
por: von Rosenstiel, I, et al.
Publicado: (2012)

P02.66. Efficacy of acupuncture for fibromyalgia - RCT
por: Vinjamury, S, et al.
Publicado: (2012)

P02.160. The psychosomatic model for clinical oncology
por: Zhirkov, A, et al.
Publicado: (2012)

P04-02. Increased breadth and potency of the neutralizing antibody response among dually-HIV-1-infected individuals
por: Powell, RL, et al.
Publicado: (2009)

P02-02 Evaluating community-based programmes for health promotion: a novel approach considering the complexity perspective
por: Huiberts, Irma, et al.
Publicado: (2022)

Stable HIV-1 envelope glycoprotein immune complexes as vaccine immunogens
por: van Montfort, Thijs, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p0grlgrek2qdbg6risqfv40psk